The originator was Schering AG (Berlex in North America), now part of Bayer HealthCare.
The largest German manufacturing facility was located in Bergkamen.
Schering-Plough | Schering | Schering AG | Ernst Christian Julius Schering | Ernst Schering | Ernst Christian Friedrich Schering |
The first orally active semisynthetic steroidal estrogen, EE (17α-ethynylestradiol), the 17α-ethynyl analog of E2, was synthesized in 1938 by Hans Herloff Inhoffen and Walter Hohlweg at Schering AG in Berlin.
The first orally active progestin, ethisterone (pregneninolone, 17α-ethynyltestosterone or 19–norandrostane), the 17α-ethynyl analog of testosterone, was synthesized in 1938 by Hans Herloff Inhoffen, Willy Logemann, Walter Hohlweg, and Arthur Serini at Schering AG in Berlin and marketed in Germany in 1939 as Proluton C and by Schering in the U.S. in 1945 as Pranone.
Bengt Samuelsson has served as a director on the boards of Pharmacia AB, NicOx SA and Schering AG and is an advisor to the venture capital fund HealthCap.